Trial intelligence / Profile preview

Human prothrombin complex concentrate in hemophilia B with bleeding

CTR20150853Phase 3Completed

Sponsor
Sichuan Yuanda Shuyang Pharmaceutical
Start
Dec 2015
Modality
Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of balfaxar in hemophilia B (HB), sponsored by Sichuan Yuanda Shuyang Pharmaceutical. Started Dec 2015; status: completed.

02

Drugs

balfaxar
03

Conditions

hemophilia B (HB)

Beyond the preview

Go deeper on CTR20150853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call